Public meets private: challenges for informed consent and umbilical cord blood banking in Canada.
This paper is a substantially modified version of a poster presented at the DNA Sampling Conference in Montreal, Quebec, June 4-7, 2006: Lorraine Sheremeta & Suzanne DeBow, "Public Meets Private: Challenges for Informed Consent and Umbilical Cord Blood Banking in Canada" DNA Sampling Conference, Montreal PQ, June...

Gene Mutation Predicts Outcome in Blood Disorder [Abstract #5].
ORLANDO, Fla., Dec. 10 /PRNewswire/ -- Both the cause and cure for polycythemia vera, a disorder of uncontrolled blood cell production, remain elusive, but researchers from the University of Florence, Italy, may be a step closer to both. Their findings are being presented today during the 48th Annual Meeting...

StemCyte(R), Inc. Receives Contract From Federal Government to Help Build National Cord Blood Inventory for United States.
ARCADIA, Calif., Nov. 8 /PRNewswire/ -- The Health Resource Service Administration (HRSA) announced today that StemCyte, Inc. has been selected to help build a national inventory of 150,000 cord blood units under the C.W. Bill Young Cell Transplantation Program. The awards were the first such disbursement of the $79...

Latest Research in Blood Diseases to be Presented at the Annual Meeting of the American Society of Hematology.
ORLANDO, Fla., Dec. 6 /PRNewswire/ -- The American Society of Hematology (ASH(TM)), the world's largest professional society of blood specialists, is expecting nearly 20,000 attendees at its 48th Annual Meeting premiering the latest in blood disease research and treatments. The event will take place December 9-12, 2006, at the...

New Chemotherapy Combinations and Alternatives for Blood Cancers Offer Patients Better Results, Improved Quality of Life.
ORLANDO, Fla., Dec. 11 /PRNewswire/ -- While chemotherapy has been a standard of care for cancer patients for decades, doctors have struggled with the dangerous side effects of the toxic therapy, focusing their research on therapies that can produce the same results without causing additional harm. This is particularly...

Medarex and PacMab Announce Therapeutic Antibody Co-Development Agreement.
PRINCETON, N.J. and SYDNEY, Australia, Nov. 7 /PRNewswire-FirstCall/ -- Medarex, Inc. and PacMab Limited, a private biopharmaceutical company, have entered into a collaborative agreement to develop novel monoclonal antibody-based therapies for blood cancers. Beginning in 2007, the companies plan to undertake clinical trials for an existing antibody...

Straight Answers.
Byline: MEDHA AMITABH DR Shashikant Apte Head, Heamatology, Sahyadri Laboratory and Haematology Center on heamatology cases. What is Haematology? Haematology is a medical specialty which concerns itself with the blood, and its generation in the bone marrow. It studies the red...

ASH Honors Congressional Champion of Stem Cell Research and Society Leaders Promoting Quality Measures.
ORLANDO, Fla., Dec. 10 /PRNewswire/ -- The American Society of Hematology (ASH(TM)), the world's largest professional society of blood specialists, is recognizing several hematologists and a United States Congressman for their tireless work as advocates for biomedical research and the practice of hematology. "I am honored to...

Sickle Cell Disease Symposium Aims to Interest High School Students in Biomedical Research.
ORLANDO, Fla., Dec. 6 /PRNewswire/ -- The American Society of Hematology (ASH(TM)), the world's largest professional society of blood specialists, will host a special symposium for high school students as part of its 48th Annual Meeting to help stimulate an interest in hematology, the biological sciences, and medical research....

Gleevec(R) Demonstrates Highest Five-Year Overall Survival Rate in History of Treatment for Patients With Chronic Myeloid Leukemia.
- New England Journal of Medicine article cites overall survival found to be 95% after excluding causes of death unrelated to CML or prior bone marrow transplantation - Gleevec results improve with long-term use - percentage of patients with no trace of disease-causing Philadelphia chromosome increased dramatically...